At CPC Scientific, we appreciate the interest and inquiries from the media regarding our business, services, and capabilities. Feel free to utilize the resources provided on this page or reach out to our media relations team for specific inquiries. We’ll ensure that you are connected with the relevant business leader or subject matter expert.
Featured CPC Scientific News
Warm Congratulations to MEDTIDE INC. on its successful listing on the Hong Kong Stock Exchange!
We are celebrating the successful listing of CPC Scientific’s parent company, MEDTIDE INC. on the Hong Kong Stock Exchange! MEDTIDE INC. announced today that its shares have officially commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 03880. The successful listing marks a significant milestone in the Company’s global pharmaceutical development journey.
News from CPC Scientific
President Theresa Cheng spoke to PhD students at Weill Cornell Graduate School, sharing industry insights and exploring how academic research today can translate into tomorrow’s cutting-edge healthcare leadership.
CPC Scientific’s Rocklin facility is undergoing a major expansion to establish a 41,000 sq ft Center of Excellence for U.S.-based peptide API manufacturing. Construction is now underway—more updates coming soon.
At CPHI Frankfurt 2025, CPC Scientific will spotlight its position as a global leader in peptide and oligonucleotide CRDMO solutions. As the company’s largest event of the year, the showcase will emphasize innovation, regulatory excellence, and a proven track record of supporting partners worldwide. Visitors can connect with CPC Scientific’s leadership and scientific team at Booth 12.0F29 to explore new opportunities and collaborations.
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the main board of the Hong Kong Stock Exchange in June 2025. This moment marks a new chapter of growth, innovation, and global impact for our organization.
We are excited to share that CPC Scientific Inc. has officially received the Good Manufacturing Practice (GMP) Certificate in accordance with the ISO 22716:2007(E) Cosmetic Guidelines.
This […]
CPC announces the completion of a rigorous four-day audit conducted by Australia’s Therapeutic Goods Administration (TGA), the country’s government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods.